PharmaCan Capital Corp (CVE:MJN)‘s stock had its “buy” rating reiterated by research analysts at Beacon Securities in a research report issued on Friday. This news story was originally reported by [[site]] and is owned by of [[site]]. If you are reading this news story on another site, it was copied illegally and reposted in violation […]
